ArticleAesthetic plastic surgery2026
Impact of Intravenous Tranexamic Acid on Postoperative Complications in Gender-Affirming Mastectomy: A Focus on Drain Output and Duration.
Article in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTranexamic acid (TXA) has been increasingly acknowledged as a beneficial pharmacological agent in plastic surgery. However, despite its proven efficacy and safety, there is limited research on its intravenous application in gender-affirming mastectomy, particularly regarding its effect on drain duration, drain output, and length of hospital stay.
methodsIn this retrospective single-center study, patients who underwent double incision mastectomy with free nipple grafts were categorized into two cohorts: one group receiving TXA and a control group without TXA utilization (TXA vs no-TXA). Demographic characteristics, surgical data, and complication rates were analyzed and compared.
resultsA total of 75 patients were included, with 34 procedures performed without the administration of TXA and 41 patients receiving TXA. The median age of the study population was 24 years (range 18-57). Postoperative bleeding requiring surgical revision was significantly less frequent in the TXA group (p = 0.038). Total drain output (p = 0.048), drain duration (p < 0.001) and length of hospital stay (p = 0.008) were significantly reduced in the TXA group. No thromboembolic events or seizures were observed.
conclusionsThis study demonstrated that intravenously administered TXA significantly reduces the incidence of postoperative hematoma, length of hospital stay, drain duration, and output after gender-affirming mastectomy. Based on these findings, we would recommend the use of TXA in double incision mastectomy with free nipple grafts to minimize the occurrence of seroma formation and major bleeding-related complications. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.